Bonus Biogroup (Israel) Market Value
| BONS Stock | ILS 17.40 0.10 0.58% |
| Symbol | Bonus |
Bonus Biogroup 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bonus Biogroup's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bonus Biogroup.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Bonus Biogroup on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Bonus Biogroup or generate 0.0% return on investment in Bonus Biogroup over 90 days. Bonus Biogroup is related to or competes with Compugen, and BioLine RX. Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts More
Bonus Biogroup Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bonus Biogroup's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bonus Biogroup upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.35 | |||
| Information Ratio | 0.1346 | |||
| Maximum Drawdown | 47.51 | |||
| Value At Risk | (7.43) | |||
| Potential Upside | 15.15 |
Bonus Biogroup Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bonus Biogroup's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bonus Biogroup's standard deviation. In reality, there are many statistical measures that can use Bonus Biogroup historical prices to predict the future Bonus Biogroup's volatility.| Risk Adjusted Performance | 0.1136 | |||
| Jensen Alpha | 0.9538 | |||
| Total Risk Alpha | 1.7 | |||
| Sortino Ratio | 0.1753 | |||
| Treynor Ratio | 0.7241 |
Bonus Biogroup Backtested Returns
Bonus Biogroup is slightly risky given 3 months investment horizon. Bonus Biogroup secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18 % return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.36% are justified by taking the suggested risk. Use Bonus Biogroup Risk Adjusted Performance of 0.1136, downside deviation of 5.35, and Mean Deviation of 4.32 to evaluate company specific risk that cannot be diversified away. Bonus Biogroup holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.14, which signifies a somewhat significant risk relative to the market. Bonus Biogroup returns are very sensitive to returns on the market. As the market goes up or down, Bonus Biogroup is expected to follow. Use Bonus Biogroup standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to analyze future returns on Bonus Biogroup.
Auto-correlation | -0.31 |
Poor reverse predictability
Bonus Biogroup has poor reverse predictability. Overlapping area represents the amount of predictability between Bonus Biogroup time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bonus Biogroup price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Bonus Biogroup price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 1.49 |
Bonus Biogroup lagged returns against current returns
Autocorrelation, which is Bonus Biogroup stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bonus Biogroup's stock expected returns. We can calculate the autocorrelation of Bonus Biogroup returns to help us make a trade decision. For example, suppose you find that Bonus Biogroup has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bonus Biogroup regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bonus Biogroup stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bonus Biogroup stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bonus Biogroup stock over time.
Current vs Lagged Prices |
| Timeline |
Bonus Biogroup Lagged Returns
When evaluating Bonus Biogroup's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bonus Biogroup stock have on its future price. Bonus Biogroup autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bonus Biogroup autocorrelation shows the relationship between Bonus Biogroup stock current value and its past values and can show if there is a momentum factor associated with investing in Bonus Biogroup.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Bonus Stock
Bonus Biogroup financial ratios help investors to determine whether Bonus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus Biogroup security.